Third Arc Bio Inc., a clinical stage biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, today announced the first ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

Appreciation isn’t just about retaining employees—it’s about engaging them at a deeper level. Leaders must recognize that ...

The Healthy Eating Index (HEI) measures dietary adherence to guidelines, highlighting its role in promoting health and ...

To regain momentum and create a growth rate and investment climate conducive to achieving key development goals, the government must take decisive action over the next four years to make some gains, ...

Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined management team as ...

A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...

March 13, 2025 We checked for new Once Human codes, and checked the validity of current codes. What are the latest Once Human codes? There are times in all of our gaming lives when we need a ...

Investigate the dual role of dairy in gut health, exploring its benefits for microbiome balance and potential adverse effects on gastrointestinal function.

Cognizant (Nasdaq: CTSH) and Boehringer Ingelheim announced today the go-live of an end-to-end technology platform powered by the Veeva Development Cloud, designed to accelerate the global ...

2-Year U.S. Treasury Note Continuous Contract $103.551 0.086 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.930 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.922 0.281 ...